Log in
Enquire now
‌

US Patent 9643925 Compounds, compositions and methods

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Cytokinetics
Cytokinetics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96439250
Patent Inventor Names
Bradley Paul Morgan0
Alex Muci0
David J. Morgans, Jr.0
Erica Anne Kraynack0
Pu-Ping Lu0
Todd Tochimoto0
Date of Patent
May 9, 2017
0
Patent Application Number
148372010
Date Filed
August 27, 2015
0
Patent Citations Received
‌
US Patent 11926592 Salts and crystal forms of omecamtiv mecarbil
0
‌
US Patent 11986474 Methods for treating heart failure by administering cardiac sarcomere activators
0
‌
US Patent 11958809 Salt of omecamtiv mecarbil and process for preparing salt
0
‌
US Patent 11702380 Synthesis of omecamtiv mecarbil
0
‌
US Patent 11753394 Synthesis of omecamtiv mecarbil
‌
US Patent 11884630 Heterocyclic compounds and their uses
0
‌
US Patent 11931358 Methods of treating heart failure with cardiac sarcomere activators
0
‌
US Patent 11780826 Bisamide sarcomere activating compounds and uses thereof
Patent Primary Examiner
‌
Alexander R Pagano
0
Patent abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9643925 Compounds, compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.